Detalhe da pesquisa
1.
Association of frailty with clinical outcomes in myelofibrosis: a retrospective cohort study.
Br J Haematol
; 194(3): 557-567, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34131896
2.
Measurable residual disease monitoring provides insufficient lead-time to prevent morphologic relapse in the majority of patients with core-binding factor acute myeloid leukemia.
Haematologica
; 106(1): 56-63, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31896684
3.
Shared-care model for complex chronic haematological malignancies.
Can Oncol Nurs J
; 31(2): 165-174, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34036155
4.
Anticoagulation prophylaxis reduces venous thromboembolism rate in adult acute lymphoblastic leukaemia treated with asparaginase-based therapy.
Br J Haematol
; 191(5): 748-754, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32395867
5.
A 14-year retrospective analysis of indications and outcomes of autologous haemopoietic stem cell transplantation in regional Queensland: a single-centre experience.
Intern Med J
; 50(2): 214-221, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32037713
6.
Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis.
Biol Blood Marrow Transplant
; 25(6): 1142-1151, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30625392
7.
Exclusion of persistent mutations in splicing factor genes and isocitrate dehydrogenase 2 improves the prognostic power of molecular measurable residual disease assessment in acute myeloid leukemia.
Haematologica
; 109(2): 671-675, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37345484
8.
Modèle de soins partagés pour les hémopathies malignes chroniques complexes.
Can Oncol Nurs J
; 31(2): 175-185, 2021.
Artigo
em Francês
| MEDLINE | ID: mdl-34036156
9.
Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study.
Bone Marrow Transplant
; 59(2): 196-202, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37938736
10.
Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms.
Leukemia
; 38(3): 502-512, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38114624
11.
Association of Factors Influencing Selection of Upfront Hematopoietic Cell Transplantation versus Nontransplantation Therapies in Myelofibrosis.
Transplant Cell Ther
; 27(7): 600.e1-600.e8, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33798769
12.
Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
Bone Marrow Transplant
; 56(8): 1908-1918, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33767401
13.
The role of hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma.
Am J Hematol
; 90(8): E145, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25913625
14.
Patterns of Ruxolitinib Therapy Failure and Its Management in Myelofibrosis: Perspectives of the Canadian Myeloproliferative Neoplasm Group.
JCO Oncol Pract
; 16(7): 351-359, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32134707
15.
Risk of Thrombosis in Adult Philadelphia-Positive ALL Treated with an Asparaginase-Free ALL Regimen.
Curr Oncol
; 28(1): 128-137, 2020 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33704181
16.
Correction: Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study.
Bone Marrow Transplant
; 59(2): 295, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38279008
17.
Emotional responses to food in adults with an eating disorder: a qualitative exploration.
Eur Eat Disord Rev
; 16(2): 115-23, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17680589
18.
Clinical Utility of Next-generation Sequencing in the Management of Myeloproliferative Neoplasms: A Single-Center Experience.
Hemasphere
; 2(3): e44, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31723772
19.
The mutational landscape of accelerated- and blast-phase myeloproliferative neoplasms impacts patient outcomes.
Blood Adv
; 2(20): 2658-2671, 2018 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30327374
20.
Distribution and Impact of Comorbidities on Survival and Leukemic Transformation in Myeloproliferative Neoplasm-Associated Myelofibrosis: A Retrospective Cohort Study.
Clin Lymphoma Myeloma Leuk
; 17(11): 774-781, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28711573